Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
TSURUHA Holdings ( (JP:3391) ) just unveiled an update.
TSURUHA Holdings has confirmed that its independent auditor has completed the interim review of the consolidated financial results for the nine months ended November 30, 2025, with no changes required to the figures disclosed on January 8, 2026. For the period from March 1 to November 30, 2025, the company reported net sales of ¥833.4 billion, operating income of ¥40.6 billion and net income attributable to owners of the parent of ¥27.0 billion, alongside total assets of ¥664.5 billion and an equity ratio of 45.0%, underscoring a solid financial position following its fiscal year-end change and five-for-one stock split.
The most recent analyst rating on (JP:3391) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on TSURUHA Holdings stock, see the JP:3391 Stock Forecast page.
More about TSURUHA Holdings
TSURUHA Holdings Inc. is a Japan-based operator of drugstores and related retail businesses, listed on the Tokyo Stock Exchange Prime Market under securities code 3391. The company focuses on selling pharmaceuticals, cosmetics, daily necessities and health-related products to consumers across its store network, positioning itself as a major player in Japan’s drugstore and healthcare retail sector.
Average Trading Volume: 2,260,623
Technical Sentiment Signal: Buy
Current Market Cap: Yen1160.9B
For a thorough assessment of 3391 stock, go to TipRanks’ Stock Analysis page.